You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Ovarian cancer

Guidance on the use of paclitaxel in the treatment of ovarian cancer

  • Technology appraisal guidance
  • Reference number: TA55
  • Published:  22 January 2003
  • Last updated:  01 May 2005
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Clinical need and practice
  • 3 The technology
  • 4 Evidence
  • 5 Implications for the NHS
  • 6 Further research
  • 7 Implementation
  • 8 Appraisal committee members
  • 9 Sources of evidence considered by the committee
  • 10 Details on criteria for audit of the use of paclitaxel in the treatment of women with ovarian cancer
  • Update information

Update information

Minor changes since publication

March 2014: Implementation section updated to clarify that paclitaxel is recommended as an option for treating ovarian cancer.

ISBN: 978-1-4731-6514-4


Previous page 10 Details on criteria for audit of the use of paclitaxel in the treatment of women with ovarian cancer
Back to top